CRNO B — Cereno Scientific AB Share News
0.000.00%
Last trade - 00:00- SEK1.50bn
- SEK1.60bn
Brief: Cereno Scientific Says Co And Abbott Enter Collaboration For Use Of Cutting-Edge Monitor Device In Upcoming Phase II Study With Cs1
Brief: Cereno Scientific Q4 Loss After Financial Items At SEK 5 109 959
Brief: Cereno Scientific Gets Patent In Japan
Brief: Cereno Scientific Signs CRO For Phase II Study With Drug Candidate CS1 In Rare Disease PAH
Brief: Cereno Scientific Q3 Pretax Loss SEK 3.1 Million
Brief: Cereno Scientific AB Says First Day For Trading For Warrants Of Series To1 And To2 Respectively Has Been Set For October 14, 2020
Brief: Cereno Scientific Completes Directed Issue Of About SEK 60 Mln
Brief: Cereno Scientific AB Says To Carry Out Directed Issue Of Units With Total Issue Proceed Of Approximately Sek 60 Million
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 4.0 Mln
Brief: Cereno Scientific Starts Cooperation With University Of Michigan
Brief: Cereno Scientific Q1 Loss After Financial Items SEK -3,752,667
Brief: Cereno Scientific's Phase II Clinical Trial Postponed Due To COVID-19
Brief: Cereno Scientific Signs Agreement With Inorbit Therapeutics
Brief: Cereno Scientific: Start Of Phase II Clinical Trial Approved In In Bulgaria
Brief: Cereno Scientific Q3 Loss After Financial Items At SEK 3 Million
Brief: Cereno Scientific Gets Approval For II Clinical Trial In Russia
Brief: Cereno Scientific Q2 Pre-Tax Loss Stable At SEK 3 Mln
Brief: Cereno Scientific Conducts Directed Issue In Connection To Oversubscribed Rights Issue
Brief: Cereno Scientific's Rights Issue Is Oversubscribed And Overallotment Issue Fully Utilized